Internal Medicine, Medical Oncology · Rockford, IL
NPI
1902833999
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
5666 East State St
Rockford, IL, 61108
Phone (815) 226-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
1,900 services
Medicare patients, 2024
553
Average age 76
Drug cost, 2024
$5.4M
1,956 prescriptions
Company payments, 2025
$22.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mete Korkmaz was code 99214 (office e&m - established), 849 times for 340 patients. In total Mete Korkmaz billed 1,900 services in 13 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 849 | 340 | $67.70 | $57K |
| 99213 Office E&M - Established | Facility | 358 | 217 | $45.74 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 300 | 121 | $60.11 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 155 | 90 | $91.34 | $14K |
| 99231 Hospital E&M - Subsequent | Facility | 61 | 40 | $38.25 | $2,333 |
| 99223 Hospital E&M - Initial | Facility | 59 | 56 | $131.47 | $7,757 |
| 99215 Office E&M - Established | Facility | 57 | 45 | $105.69 | $6,025 |
| 99222 Hospital E&M - Initial | Facility | 53 | 48 | $100.76 | $5,341 |
By year: 2022 $111K for 1,576 services; 2023 $135K for 1,805 services; 2024 $128K for 1,900 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mete Korkmaz prescribed most often to Medicare patients was Anastrozole, with 173 prescriptions and refills. In total Mete Korkmaz wrote 1,956 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 173 | 499 | 57 | $3,190 |
| Ondansetron Hcl Generic | 156 | 156 | 99 | $764 |
| Prochlorperazine Maleate Generic | 129 | 129 | 94 | $1,581 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 105 | 105 | 46 | $2,651 |
| Prednisone Generic | 97 | 135 | 38 | $460 |
| Xarelto Rivaroxaban | 93 | 176 | 21 | $97K |
| Potassium Chloride Generic | 69 | 164 | 32 | $1,275 |
| Dexamethasone Generic | 63 | 76 | 34 | $1,027 |
| Letrozole Generic | 54 | 140 | 14 | $538 |
| Eliquis Apixaban | 50 | 112 | 22 | $66K |
| Imbruvica Ibrutinib | 48 | 48 | Under 11 | $750K |
| Furosemide Generic | 45 | 115 | 16 | $280 |
| Hydroxyurea Generic | 36 | 88 | Under 11 | $857 |
| Abiraterone Acetate Generic | 34 | 34 | Under 11 | $90K |
| Olanzapine Generic | 34 | 50 | 29 | $177 |
Brand drugs: 497 claims; generic drugs: 1,459 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mete Korkmaz $22.78 ($22.78 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Scientific Affairs, LLC with $22.78.
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC JNJ | 1 | $22.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.